Clinical Data licenses cancer drug for $252M |  |
|
Posted by Mary Canady August 13th, 2009 .
| |
| No Comments |
Clinical Data Inc. said Thursday it licensed a potential cancer treatment to CombinatoRx in a deal worth as much as $252 million, plus royalties on sales.
See other entries categorized in News, San Diego Union Tribune, Syndication.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
